RIGEL PHARMACEUTICALS INC — Director's Dealing 2018

Apr 25, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2018-04-20

Reporting Person: Duliege Anne-Marie (EVP & Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-20	Common Stock	S	5000	$4.11	Disposed	0	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018.

F2: The Reporting Person purchased these shares on December 29, 2017 under the Employee Stock Purchase Plan.